These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7698189

  • 21. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS, Colpaert FC, Pauwels PJ.
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [Abstract] [Full Text] [Related]

  • 22. 5-HT autoreceptors in the regulation of 5-HT release from guinea pig raphe nucleus and hypothalamus.
    Moret C, Briley M.
    Neuropharmacology; 1997 May; 36(11-12):1713-23. PubMed ID: 9517443
    [Abstract] [Full Text] [Related]

  • 23. Effects of 5-HT and 5-HT1A receptor agonists and antagonists on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
    Wang Y, Jones JF, Ramage AG, Jordan D.
    Br J Pharmacol; 1995 Oct; 116(4):2291-7. PubMed ID: 8564262
    [Abstract] [Full Text] [Related]

  • 24. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT.
    Behav Brain Res; 1996 Oct; 73(1-2):337-53. PubMed ID: 8788530
    [Abstract] [Full Text] [Related]

  • 25. Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein.
    Razzaque Z, Longmore J, Hill RG.
    Eur J Pharmacol; 1995 Sep 05; 283(1-3):199-206. PubMed ID: 7498311
    [Abstract] [Full Text] [Related]

  • 26. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 05; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 27. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
    Bosker FJ, de Winter TY, Klompmakers AA, Westenberg HG.
    J Neurochem; 1996 Jun 05; 66(6):2546-55. PubMed ID: 8632181
    [Abstract] [Full Text] [Related]

  • 28. Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro.
    Maura G, Raiteri M.
    J Neurochem; 1996 Jan 05; 66(1):203-9. PubMed ID: 8522955
    [Abstract] [Full Text] [Related]

  • 29. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ, Curtis MJ.
    Br J Pharmacol; 1997 Nov 05; 122(5):875-84. PubMed ID: 9384503
    [Abstract] [Full Text] [Related]

  • 30. The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs.
    Hagan JJ, Hatcher JP, Slade PD.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):743-51. PubMed ID: 8750741
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
    Corradetti R, Le Poul E, Laaris N, Hamon M, Lanfumey L.
    J Pharmacol Exp Ther; 1996 Aug 29; 278(2):679-88. PubMed ID: 8768719
    [Abstract] [Full Text] [Related]

  • 32. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
    Fornal CA, Metzler CW, Gallegos RA, Veasey SC, McCreary AC, Jacobs BL.
    J Pharmacol Exp Ther; 1996 Aug 29; 278(2):752-62. PubMed ID: 8768728
    [Abstract] [Full Text] [Related]

  • 33. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q, Wichems C, Heils A, Van De Kar LD, Lesch KP, Murphy DL.
    J Pharmacol Exp Ther; 1999 Dec 29; 291(3):999-1007. PubMed ID: 10565817
    [Abstract] [Full Text] [Related]

  • 34. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG, Beneytez ME, Delgado M, Manzanares J, López-Rodríguez ML, Benhamu B, Morcillo MJ, Pozo MA, Rubia FJ, Fuentes JA.
    Pharmacology; 2001 May 29; 62(4):234-42. PubMed ID: 11360001
    [Abstract] [Full Text] [Related]

  • 35. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus.
    Mundey MK, Fletcher A, Marsden CA.
    Neuropharmacology; 1994 Jan 29; 33(1):61-6. PubMed ID: 8183439
    [Abstract] [Full Text] [Related]

  • 36. GR127935: a potent and selective 5-HT1D receptor antagonist.
    Skingle M, Beattie DT, Scopes DI, Starkey SJ, Connor HE, Feniuk W, Tyers MB.
    Behav Brain Res; 1996 Jan 29; 73(1-2):157-61. PubMed ID: 8788495
    [Abstract] [Full Text] [Related]

  • 37. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices.
    Pugliese AM, Passani MB, Corradetti R.
    Br J Pharmacol; 1998 May 29; 124(1):93-100. PubMed ID: 9630348
    [Abstract] [Full Text] [Related]

  • 38. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 29; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 39. Electrophysiological effects of WAY 100635, a new 5-HT1A receptor antagonist, on dorsal raphe nucleus serotoninergic neurones and CA1 pyramidal cells in vitro.
    Corradetti R, Pugliese AM, Le Poul E, Laaris N, Hamon M, Lanfumey L.
    Acta Physiol Hung; 1996 Mar 29; 84(4):407-9. PubMed ID: 9328615
    [Abstract] [Full Text] [Related]

  • 40. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L, Haj-Dahmane S, Hamon M.
    Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.